50% off Premium Yearly
Cineplex IncCGX.TOCOMMENTMay 22, 2014Stock price when the opinion was issued
As of Jun 19, 2026. Market Open.
Revenue growth is coming back a bit, with lower comparables from last year helping the year-over-year figures. Its debt levels are high, with net debt of $1.9B, and a net debt/EBITDA of 6.8X. Interest costs are $137M (last 12 months) and these will likely rise a bit with higher rates. 12-month cash flow was $116M and therein lies the problem. The debt is mostly due in the next five years. With attendance back, and a decent film slate, bankruptcy is becoming less of a concern, but it is still hard to paint a really positive picture here because of the leverage.
It is somewhat cheap (0.4X forward sales), but also has a fairly high forward P/E of 20.2X. It could become a takeover target, however, we would not place a high level of probability on that at these current levels.
Unlock Premium - Try 5i Free
Cineplex remains a recovery story, and its beta of 2.88 signals more risk than usual. It rose 10% in Q1, but the chart was choppy. So, consider Cineplex a partial buy. After all, Covid didn’t kill cinema-going, as some expected, but deferred it. We still love the big screen. Read Dark horses: Nuvei, Cineplex, Boralex for our full analysis.
Attracted to this. Pretty much the dominant monopoly supplier of big picture movies in Canada. Pays a nice dividend of around 6%. He didn’t buy this because of its higher valuation. Stock has run up a lot and he doesn’t see a huge uplift in people going to movies. A bit of a mature segment and is also very cyclical for the kind of movies coming out. Concessions and ads are where their huge profit margins are. Good management. Trades at around 24X estimated earnings and he would prefer it sub 20.